![Marc Gitzinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 4 M $ in data 31/05/2026
Marc Gitzinger is the founder of BioVersys AG, holding the title of Chief Executive Officer & Director since 2008.
Dr. Gitzinger is the founder of Beam Alliance, holding the title of Chairman.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
BIOVERSYS AG 1,97% | 31/12/2025 | 115.000 ( 1,97% ) | 4 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIOVERSYS AG | Fondatore | 24/09/2008 |
Beam Alliance
 Beam Alliance Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which develops products to tackle antimicrobial resistance | Presidente | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 2 |
|---|---|
BioVersys AG
 BioVersys AG BiotechnologyHealth Technology Engages in research and development of small molecules on novel bacterial targets with application of AMR & antibiotic drugs | Health Technology |
Beam Alliance
Beam Alliance Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which develops products to tackle antimicrobial resistance | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
